Patent · US Expired

Benzonaphthyridine

US6384047B1 · kind B1 · utility

4Cited by

1References

9Claims

0Family size

Assignee

Byk Gulden Lomberg Chemische Fabrik GmbH · DE

Inventors

Dieter Flockerzi · Allensbach, DE
Armin Hatzelmann · Konstanz, DE

Key dates

Filing date	Dec 3, 1999
Grant date	May 7, 2002
Priority date	—
Expiry date	Dec 3, 2019

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds 8,9-diethoxy-2-methyl-6-[4(p-toluenesulfonamide) phenyl]-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridine and 9-ethoxy-8-methoxy-2-methyl-6-[4-(p-toluenesulfonamido)phenyl]-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridine and medicament compositions based thereon are useful for treating airway disorders, high blood pressure disorders and concomitant disorders connected therewith.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.